International Journal For Multidisciplinary Research

E-ISSN: 2582-2160   •   Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 7, Issue 3 (May-June 2025) Submit your research before last 3 days of June to publish your research paper in the issue of May-June.
Submit Research Paper Join as a Reviewer

Plagiarism is checked by the leading plagiarism checker TurnItIn

Call for Paper

Volume 7 Issue 3
May-June 2025

Submit your research paper

Indexing Partners
Academia Advanced Sciences Index Bielefeld Academic Search Engine CiteSeer DRJI Google Scholar Independent Search Engine & Directory Network ISI (International Scientific Indexing) Issuu Mendeley Research Networks
RefSeek ResearcherId - Thomson Reuters ResearchGate Scirus Scribd Semantic Scholar UTeM - Universiti Teknikal Malaysia Melaka Wiki for Call for Papers WorldCat Zenodo

Formulation And Evaluation Of The Dolutegravir Nanocrystals

Author(s) Asst.Prof. Suraj Ram Mashale, Dr. B D Tiwari, Ms. Muskan Mainoddin Mulla, Ms. Pratiksha Ashok Munde
Country India
Abstract Drugs with low water solubility may be delivered more easily with the help of nanocrystals. The use of low energy anti-solvent precipitation to create nanocrystals has been examined in this work, for the anti-retroviral medication dolutegravir, which is essentially poorly insoluble in water, stable nanocrystals with consistent particle sizes were created. Due to its limited water solubility, dolutegravir, a powerful HIV integrase inhibitor, has problems that impact both its bioavailability and effectiveness. The purpose of this study was to improve the solubility and bioavailability of dolutegravir by creating oral nanocrystal tablets. A bottom-up method was used to create the nanocrystals, and appropriate excipients were used to stabilize them. When compared to the pure medication, the optimized nanocrystal formulation showed better solubility and dissolution rates.The nanocrystal powder was used to produce oral tablets, which were then tested for pharmacokinetic profile and effectiveness in HIV-infected cells. The results demonstrated that the oral nanocrystal Dolutegravir tablets had better bioavailability and efficacy. This innovative formulation strategy has the potential to enhance HIV patients' treatment results.
Keywords Dolutegravir, Nanocrystals,Anti-solvent technique,Tablet dosage form.
Field Medical / Pharmacy
Published In Volume 7, Issue 3, May-June 2025
Published On 2025-05-17
DOI https://doi.org/10.36948/ijfmr.2025.v07i03.43985
Short DOI https://doi.org/g9kf8h
View / Download PDF File

Share this



E-ISSN 2582-2160
CrossRef

CrossRef DOI is assigned to each research paper published in our journal.

IJFMR DOI prefix is
10.36948/ijfmr

Downloads
Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 7 Isu 3Cover Page Vol 7 Isu 2Cover Page Vol 7 Isu 1

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA Open Access

About IJFMR
Fees & Payment
Current Issue
Publication Archive 		Submit Research Paper
Track Submission Status
Publication Guidelines
Publication Ethics
Peer Review & Plagiarism 		Join as a Reviewer
Editors & Reviewers
Reviewer Referral Program
Get Reviewer Membership Certi. 		Website/Journal Policies
Usage Policy
Content Policies
Privacy Policy
Contact Us +91-9687-828-838 editor@ijfmr.com